Pure Bioscience, Inc. (PURE) Narrows Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.07 -12.5%
Financial Fact:
Selling, general and administrative: 1.22M
Today's EPS Names:
SICP, MNSB, CFFI, More
Financial Fact:
Selling, general and administrative: 1.22M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
Pure Bioscience, Inc. (: PURE) reported Q3 EPS of ($0.07), versus ($0.14) reported last year. Revenue for the quarter came in at $261 thousand, versus $258 thousand reported last year.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- StoneX Reiterates Hold Rating on BOK Financial (BOKF)
- NVR, Inc. (NVR) Misses Q3 EPS by 1332c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
